Cronos Group Inc. - Common Share (CRON): Price and Financial Metrics

Cronos Group Inc. - Common Share (CRON): $3.93

0.03 (+0.77%)

POWR Rating

Component Grades













Add CRON to Watchlist
Sign Up

Industry: Agriculture


of 29

in industry


  • CRON scores best on the Sentiment dimension, with a Sentiment rank ahead of 13.5% of US stocks.
  • CRON's strongest trending metric is Quality; it's been moving down over the last 157 days.
  • CRON ranks lowest in Quality; there it ranks in the 0th percentile.

CRON Stock Summary

  • For CRON, its debt to operating expenses ratio is greater than that reported by merely 9.49% of US equities we're observing.
  • With a price/sales ratio of 25.8, Cronos Group Inc has a higher such ratio than 93.17% of stocks in our set.
  • Revenue growth over the past 12 months for Cronos Group Inc comes in at 81.99%, a number that bests 91.84% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Cronos Group Inc are AXGN, REKR, ISR, VCYT, and SNES.
  • Visit CRON's SEC page to see the company's official filings. To visit the company's web site, go to

CRON Valuation Summary

  • CRON's EV/EBIT ratio is -10; this is 134.13% lower than that of the median Healthcare stock.
  • Over the past 43 months, CRON's price/sales ratio has gone down 2628.2.
  • Over the past 43 months, CRON's price/sales ratio has gone down 2628.2.

Below are key valuation metrics over time for CRON.

Stock Date P/S P/B P/E EV/EBIT
CRON 2021-08-31 43.4 1.5 -16.8 -10.0
CRON 2021-08-30 42.1 1.5 -16.3 -9.5
CRON 2021-08-27 42.5 1.5 -16.5 -9.7
CRON 2021-08-26 42.1 1.5 -16.3 -9.5
CRON 2021-08-25 42.7 1.5 -16.5 -9.8
CRON 2021-08-24 43.3 1.5 -16.7 -10.0

CRON's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CRON has a Quality Grade of F, ranking ahead of 0.86% of graded US stocks.
  • CRON's asset turnover comes in at 0.03 -- ranking 353rd of 682 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows CRON's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.030 -0.621 -0.378
2021-03-31 0.027 -0.439 -0.870
2020-12-31 0.024 -0.553 -0.242
2020-09-30 0.019 -0.749 0.191
2020-06-30 0.015 -1.350 2.033
2020-03-31 0.014 -1.185 6.271

CRON Price Target

For more insight on analysts targets of CRON, see our CRON price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.63 Average Broker Recommendation 2.42 (Moderate Sell)

CRON Stock Price Chart Interactive Chart >

Price chart for CRON

CRON Price/Volume Stats

Current price $3.93 52-week high $15.83
Prev. close $3.90 52-week low $3.74
Day low $3.79 Volume 1,915,200
Day high $3.94 Avg. volume 2,353,320
50-day MA $4.55 Dividend yield N/A
200-day MA $6.53 Market Cap 1.47B

Cronos Group Inc. - Common Share (CRON) Company Bio

Cronos Group seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations. The firm typically invests in companies based in Canada. Cronos Group was founded in January, 2013 and is based in Toronto, Canada.

CRON Latest News Stream

Event/Time News Detail
Loading, please wait...

CRON Latest Social Stream

Loading social stream, please wait...

View Full CRON Social Stream

Latest CRON News From Around the Web

Below are the latest news stories about Cronos Group Inc that investors may wish to consider to help them evaluate CRON as an investment opportunity.

Cronos Group Provides Bi-Weekly MCTO Status Update

TORONTO, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). On November 9, 2021, the Company announced that it applied for a management cease trade order (“MCTO”) with the applicable securities regulatory authorities in Canada on the basis that the Company would

Yahoo | January 14, 2022

2 Pot Stocks To Flat Out Avoid in 2022

Despite the dip last year, the marijuana industry consists of excellent growth stocks that have the potential to flourish in the coming years. The U.S. cannabis companies, in particular, saw drastic revenue growth amid the ongoing pandemic. The ramp-up of state legalization also gave a boost to marijuana sales.

Yahoo | January 14, 2022

Are Any Marijuana Stocks On U.S. Exchanges Buys After Tilray Gives Sector A Break?

The descent for Canadian marijuana stocks continued last year, as expectations dimmed for cannabis reform in the U.S.

Yahoo | January 12, 2022

7 Penny Stocks to Buy for January

These penny stocks look poised for a rally in January 2022 and can possibly deliver multi-fold returns in the next 12 months.

Faisal Humayun on InvestorPlace | January 10, 2022

Why Cronos Group Stock Slumped 14% in December

The company delayed the release of an SEC filing and got dragged down by the broad downturn in cannabis stocks.

The Motley Fool | January 7, 2022

Read More 'CRON' Stories Here

CRON Price Returns

1-mo -8.82%
3-mo -32.24%
6-mo -45.64%
1-year N/A
3-year -73.62%
5-year 183.78%
YTD 0.26%
2021 -43.52%
2020 -9.52%
2019 -26.18%
2018 34.43%
2017 600.87%

Continue Researching CRON

Here are a few links from around the web to help you further your research on Cronos Group Inc's stock as an investment opportunity:

Cronos Group Inc (CRON) Stock Price | Nasdaq
Cronos Group Inc (CRON) Stock Quote, History and News - Yahoo Finance
Cronos Group Inc (CRON) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8193 seconds.